Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6-14 years in China and its applications in high-obesity-risk countries and regionsResearch in context

• Main Authors: Yunfei Liu (Author), Youxin Wang (Author), Yunfei Xing (Author), Maike Wolters (Author), Di Shi (Author), Pingping Zhang (Author), Jiajia Dang (Author), Ziyue Chen (Author), Shan Cai (Author), Yaqi Wang (Author), Jieyu Liu (Author), Xinxin Wang (Author), Haoyu Zhou (Author), Miao Xu (Author), Lipo Guo (Author), Yuanyuan Li (Author), Jieyun Song (Author), Jing Li (Author), Yanhui Dong (Author), Yanchun Cui (Author), Peijin Hu (Author), Antje Hebestreit (Author), Hai-Jun Wang (Author), Li Li (Author), Jun Ma (Author), Yee Hui Yeo (Author), Hui Wang (Author), Yi Song (Author)
• Format: Book
• Published: Elsevier, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Background: The prevalence of metabolic-associated steatotic liver disease (MASLD) is rising precipitously among children, particularly in regions or countries burdened with high prevalence of obesity. However, identifying those at high risk remains a significant challenge, as the majority...